Prevalence of hypothyroidism among MDR-TB patients in Botswana
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i


Prevalence of hypothyroidism among MDR-TB patients in Botswana
  • Published Date:

    Nov 2012

  • Source:
    Int J Tuberc Lung Dis. 16(11):1561-1562
  • Language:
    English

You May Also Like:

  1. Personal Author:
    D’Ambrosio, Lia ; Centis, Rosella ; ...
    Published Date:
    Nov 29 2012
    Source:
    N Engl J Med. 367(22):2154-2156.
    File Type:
    Filetype[PDF - 32.34 KB]
    File Type:
    Filetype[PDF - 32.34 KB]
  2. Personal Author:
    Click, E. S. ; Chirenda, J. ; ...
    Published Date:
    Nov 2014
    Source:
    Int J Tuberc Lung Dis. 18(11):1319-1322
    Description:
    We linked results from the Fourth Botswana National Drug Resistance Survey (DRS), 2007-2008, to patient records from the national Electronic Tuberculo...
    File Type:
    Filetype[PDF - 239.87 KB]
    File Type:
    Filetype[PDF - 239.87 KB]
  3. Personal Author:
    Aung, Htin Lin ; Nyunt, Wint Wint ; ...
    Published Date:
    November 2018
    Source:
    Emerg Infect Dis. 24(11):2134
    File Type:
    Filetype[PDF - 564.48 KB]
    File Type:
    Filetype[PDF - 564.48 KB]
  4. Personal Author:
    Kurbatova, Ekaterina V. ; Cavanaugh, Joseph S. ; ...
    Published Date:
    Jul 09 2013
    Source:
    Clin Infect Dis. 57(8):1081-1093.
    Description:
    IntroductionPyrazinamide (PZA) is essential in tuberculosis (TB) treatment. We describe the prevalence, trends and predictors of PZA resistance in Myc...
    File Type:
    Filetype[PDF - 971.83 KB]
    File Type:
    Filetype[PDF - 971.83 KB]
  5. Personal Author:
    Ahuja, Shama D. ; Ashkin, David ; ...
    Corporate Authors:
    Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TBA
    Published Date:
    Aug 28 2012
    Source:
    PLoS Med. 2012; 9(8).
    Description:
    BackgroundTreatment of multidrug resistant tuberculosis (MDR-TB) is lengthy, toxic, expensive, and has generally poor outcomes. We undertook an indivi...
    File Type:
    Filetype[PDF - 662.59 KB]
    File Type:
    Filetype[PDF - 662.59 KB]